GTC Biotherapeutics Inc. (GTCB1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
175 CROSSING BLVD FRAMINGHAM, MA 01701

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

GTC Biotherapeutics Inc. develops, produces, and commercializes therapeutic proteins in the milk of transgenic animals. Focuses on using transgenic technology to establish commercial production systems for products that are anticipated to require large production volume or are difficult to express.

View SEC Filings from GTCB1 instead.

View recent insider trading info

Funds Holding GTCB1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GTCB1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TUCK ALAN W

  • Director
17,497 2010-09-30 0

BULLOCK FRANCIS J

  • Director
21,226 2010-09-30 0

MCNAMARA PAMELA W

  • Director
8,494 2010-07-02 0

HEIDEN WILLIAM K CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
0 2010-06-15 0

LFB BIOTECHNOLOGIES S.A.S.U.

  • Director
  • 10% Owner
  • DIRECTOR BY DEPUTIZATION
0 2010-06-15 0

SCOTLAND RICHARD A SENIOR VP, REGULATORY AFFAIRS

  • Officer
32,385 2010-01-19 0

GERAGHTY JAMES A

  • Director
19,163 2009-12-31 0

COX GEOFFREY F PRESIDENT, CEO AND CHAIRMAN

  • Officer
  • Director
85,754 2009-11-02 0

MEADE HARRY SVP, TRANSGENIC RESEARCH

  • Officer
34,754 2009-11-02 0

WOLOSHEN DANIEL S SENIOR VP AND GENERAL COUNSEL

  • Officer
27,319 2009-11-02 0

GREEN JOHN B SENIOR VP AND CFO

  • Officer
30,334 2009-11-02 0

NGUYEN EVELYNE

  • Director
133 2009-10-01 0

MEROT BERTRAND

  • Director
0 2009-10-01 0

PROST JEAN FRANCOIS

  • Director
0 2009-10-01 0

MILLER MARVIN

  • Director
3,585 2009-09-25 0

BECHON CHRISTIAN

  • Director
  • 10% Owner
2,028,188 2009-09-25 0

BAUER KENNETH

  • Director
0 2009-05-27 0

GRAY MARY ANN

  • Director
0 2008-06-24 0

LIPOSKY GREGORY F SENIOR VP, OPERATIONS

  • Officer
68,082 2008-03-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments